-
+3 +3
Roche’s Ocrelizumab Found to be Superior to Standard Interferon Therapy in Relapsing Multiple Sclerosis Patients
Read about How Roche’s Ocrelizumab Found to be Superior to Standard Interferon Therapy in Relapsing Multiple Sclerosis Patients.
-
+2 +2
Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis
The early diagnosis of certain types of cancer, as well as nervous system diseases such as multiple sclerosis and neuromyelitis optica, may soon be facilitated by the use of a nanometric sensor capable of identifying biomarkers of these pathological conditions.
-
+2 +2
Ilona Bidzan's multiple sclerosis documentary (Polish, captioned in English)
The 20-minute documentary was filmed in Poland and both written and directed by the psychologist Ilona Bidzan. The film is focused on the stories of the painter Emilia Ratajczak, photographer Wojciech Stańko, and dancer Gabriela Zenka. Despite the different ages and stages of life, they share a disease and a desire to change their lives, fighting the difficulties that come with an MS diagnosis.
-
+2 +2
Novartis' Gilenya Found to Have Long-Term Positive Effects on Patients with Relapsing-Remitting Multiple Sclerosis
Read about the finding that fingolimod has long-term positive effects on patients with relapsing-remitting multiple sclerosis.
-
+3 +2
Most uses of medical marijuana wouldn't pass FDA review, study finds
Medical marijuana may improve muscle spasms in people with multiple sclerosis, study concludes.
-
+12 +2
The Orion Conference: Turning Big Data Into Knowledge | Multiple Sclerosis Discovery Forum
A conference in Cambridge, Massachusetts, outlined progress and challenges in turning computational modeling into actionable knowledge in MS and other brain disorders
-
+2 +2
Multiple Sclerosis Research: Listeria with Alemtuzumab - 2 cases reported
Here we report two patients treated with alemtuzumab for MS developing Listeria meningitis few days after the first infusion cycle. Both patients recovered completely after prompt diagnosis and adequate treatment. Physicians and patients should be aware of this serious, but treatable complication.
-
+2 +2
Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis
Pract Neurol doi:10.1136/practneurol-2015-001139
-
+10 +2
Study Reveals Brain Network Responsible for Cognitive Changes in Multiple Sclerosis
Analysis of the fMRI data revealed that while completing this measure, MS patients showed weaker functional connections with dorsolateral prefrontal cortex.
-
+2 +2
Mitochondria May Play a Role in MS Development and Progression - Multiple Sclerosis News Today
Read about how mitochondria may play a role in multiple sclerosis development and progression.
-
+2 +2
Report shows people with advanced MS miss out on access to palliative care services. | News | MS Trust - Information, education, research and support
25 June 2015: Report shows people with advanced MS miss out on access to palliative care services.
-
+8 +3
Multiple Sclerosis, Vitamin D, and the Microbiome
The panelists discuss vitamin D levels and multiple sclerosis risk, noting that there is some evidence suggesting vitamin D level has some impact on disease severity in multiple sclerosis. They also briefly discuss the gut microbiome and the potential role played by intestinal flora in disease risk.
-
+11 +3
Think of Multiple Sclerosis as a Leaking Swimming Pool
Interesting analogy and unification theory
-
+19 +3
The alphabet of months: a year of living with multiple sclerosis
My daughter took her first steps on the day I was diagnosed – a juxtaposition so perfect, so trite, so filled with the tacky artifice of real life that I am generally too ashamed to tell anyone about it. By Christian Donlan.
-
+2 +2
Multiple Sclerosis Research: trial of oral vs. intravenous steroids
"Interestingly, in a fee-for-service healthcare environment neurologists still prefer admitting MSers and using the IV route over the oral route; this way they can charge for seeing their patients daily and for the cost of giving an infusion."
-
+2 +2
Nano-Drugs in Liposomes Could Treat Multiple Sclerosis
Nano-drugs encased in liposomes could one day be used to treat neurological diseases like multiple sclerosis (MS), according to a new study published July 6th in the journal, PloS One.
-
+2 +2
Study Finds Physical Activity and Exercise Have Considerable Health Benefits for MS Patients
In a recent study published in the International Journal of Molecular Sciences, a team of researchers from Germany identified an association between increased physical activity and improved mental health in patients with Multiple Sclerosis (MS).
-
+2 +2
Study Shows Skin Problems Can Be Caused by Interferon-β MS Therapy
Skin problems may be caused by interferon-β, a common treatment for multiple sclerosis (MS), according to a new study published by a German research group at the Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, in Würzburg, Germany.
-
+2 +2
Multiple Sclerosis Research: Bye Bye Yuti
One of the instrumental researchers behind interferon beta therapy is retiring.
-
+5 +2
Parasites by Post: The Online Black Market for Therapeutic Worms
Some swear by Helminthic therapy, infesting themselves with parasitic worms to treat autoimmune and inflammatory conditions—except the treatment is far from doctor approved.
Submit a link
Start a discussion